Immune thrombocytopenia (ITP) is a rare and orphan disease. The following
recommendations are meant to assist physicians, dentists, and other health-care …

Immune thrombocytopenia (ITP) is now well‐known to reduce patients' health‐related
quality of life. However, data describing which signs and symptoms patients and physicians …

Immune thrombocytopenia (ITP) is a disease of heterogenous origin characterized by low
platelet counts and an increased bleeding tendency. Three disease phases have been …

Background Immune thrombocytopenia (ITP) is an acquired immune-mediated bleeding
disorder characterized by isolated thrombocytopenia. Its estimated yearly incidence in the …

Pediatric chronic immune thrombocytopenia (cITP) is a heterogeneous condition in terms of
bleeding severity, second‐line treatment use, association with clinical and/or biological …

Background: Mindfulness is our innate capacity to pay full, conscious, and compassionate
attention to something in the moment. It is also a skill that can be strengthened by mental …

Immune thrombocytopenia (ITP) is the most common acquired thrombocytopenia in children
and is caused by immune-mediated decreased platelet production and increased platelet …

It is known that patients with immune thrombocytopenia (ITP) have fatigue and impairment of
health‐related quality of life (HRQoL). However, it is hypothesized that patients with …

Background Fatigue is an important clinical and psychological aspect for a significant
number of children affected by immune thrombocytopenia (ITP). To date, few studies have …

Background Fatigue in immune thrombocytopenia (ITP) is frequent and burdensome, but we
lack the knowledge to help these patients. Aim The aim of the study is to explore the role of …